DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,038 filers reported holding DANAHER CORPORATION in Q4 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $454,472,013 | +4.2% | 1,815,209 | +4.0% | 0.28% | -6.1% |
Q1 2024 | $435,945,014 | +12.0% | 1,746,222 | +3.9% | 0.30% | -12.7% |
Q4 2023 | $389,082,071 | +4.3% | 1,681,414 | +3.4% | 0.34% | -12.6% |
Q3 2023 | $372,967,043 | -8.7% | 1,625,656 | -4.4% | 0.39% | -6.7% |
Q2 2023 | $408,354,581 | +5.1% | 1,701,208 | +10.2% | 0.42% | -10.5% |
Q1 2023 | $388,616,631 | -13.1% | 1,543,588 | -8.5% | 0.46% | -9.5% |
Q4 2022 | $447,222,279 | +49.3% | 1,687,737 | +46.4% | 0.51% | +5.1% |
Q3 2022 | $299,634,000 | -9.7% | 1,152,758 | -11.9% | 0.49% | +5.4% |
Q2 2022 | $331,700,000 | -22.0% | 1,308,501 | -9.4% | 0.46% | -10.1% |
Q1 2022 | $425,310,000 | -10.9% | 1,444,347 | -0.4% | 0.52% | +17.3% |
Q4 2021 | $477,093,000 | +38.5% | 1,449,684 | +28.5% | 0.44% | +26.4% |
Q3 2021 | $344,543,000 | +9.9% | 1,128,584 | -3.2% | 0.35% | +3.9% |
Q2 2021 | $313,509,000 | +16.9% | 1,166,411 | -2.3% | 0.34% | +6.0% |
Q1 2021 | $268,277,000 | +6.5% | 1,193,441 | +4.9% | 0.32% | -6.0% |
Q4 2020 | $251,966,000 | +22.8% | 1,138,004 | +19.2% | 0.34% | +2.4% |
Q3 2020 | $205,113,000 | +34.7% | 955,048 | +10.9% | 0.33% | +13.5% |
Q2 2020 | $152,329,000 | +21.6% | 861,437 | -4.4% | 0.29% | -0.7% |
Q1 2020 | $125,231,000 | -22.1% | 900,767 | -13.4% | 0.29% | +3.9% |
Q4 2019 | $160,836,000 | +15.2% | 1,040,708 | +7.7% | 0.28% | +7.3% |
Q3 2019 | $139,583,000 | -2.9% | 966,440 | -3.9% | 0.26% | -4.0% |
Q2 2019 | $143,743,000 | +5.4% | 1,005,762 | -2.6% | 0.27% | +9.7% |
Q1 2019 | $136,366,000 | +37.5% | 1,032,916 | +7.4% | 0.25% | +34.8% |
Q4 2018 | $99,154,000 | -13.4% | 961,451 | -8.8% | 0.18% | 0.0% |
Q3 2018 | $114,561,000 | +10.9% | 1,054,230 | +0.7% | 0.18% | 0.0% |
Q2 2018 | $103,305,000 | -30.3% | 1,047,060 | -30.8% | 0.18% | -16.7% |
Q1 2018 | $148,139,000 | +13.1% | 1,512,607 | +7.2% | 0.22% | +16.3% |
Q4 2017 | $130,932,000 | +25.4% | 1,410,668 | +15.9% | 0.19% | +13.8% |
Q3 2017 | $104,453,000 | +32.1% | 1,217,641 | +30.0% | 0.17% | +14.4% |
Q2 2017 | $79,065,000 | +4.0% | 936,899 | +5.4% | 0.15% | -8.2% |
Q1 2017 | $76,053,000 | +21.1% | 888,958 | +10.2% | 0.16% | +8.2% |
Q4 2016 | $62,784,000 | +21.5% | 806,575 | +22.3% | 0.15% | +14.0% |
Q3 2016 | $51,678,000 | -33.1% | 659,538 | -13.8% | 0.13% | -39.4% |
Q2 2016 | $77,253,000 | +9.7% | 765,050 | +3.0% | 0.21% | +7.6% |
Q1 2016 | $70,450,000 | -35.9% | 742,604 | -37.2% | 0.20% | -25.3% |
Q4 2015 | $109,858,000 | +27.3% | 1,182,618 | +16.7% | 0.26% | +22.1% |
Q3 2015 | $86,285,000 | -24.6% | 1,013,234 | -24.2% | 0.22% | -7.3% |
Q2 2015 | $114,423,000 | -11.9% | 1,337,150 | -12.6% | 0.23% | -6.0% |
Q1 2015 | $129,899,000 | +49.1% | 1,529,796 | +50.5% | 0.25% | +37.6% |
Q4 2014 | $87,129,000 | -21.1% | 1,016,452 | -30.0% | 0.18% | -21.6% |
Q3 2014 | $110,393,000 | -4.9% | 1,452,954 | -1.4% | 0.23% | -8.0% |
Q2 2014 | $116,052,000 | +16.5% | 1,473,797 | +10.9% | 0.25% | +5.5% |
Q1 2014 | $99,646,000 | +38.7% | 1,329,289 | +42.8% | 0.24% | +27.3% |
Q4 2013 | $71,860,000 | +33.8% | 931,068 | +20.2% | 0.19% | +27.2% |
Q3 2013 | $53,715,000 | +23.4% | 774,544 | +12.7% | 0.15% | +12.2% |
Q2 2013 | $43,518,000 | +15.3% | 687,467 | +13.2% | 0.13% | -4.4% |
Q1 2013 | $37,750,000 | +22.4% | 607,401 | +10.1% | 0.14% | +15.1% |
Q4 2012 | $30,849,000 | -32.1% | 551,834 | -33.0% | 0.12% | -33.5% |
Q3 2012 | $45,426,000 | +16.2% | 823,650 | +9.7% | 0.18% | +1.1% |
Q2 2012 | $39,091,000 | -9.7% | 750,609 | -2.9% | 0.18% | -6.8% |
Q1 2012 | $43,289,000 | – | 773,013 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |